Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.18 | -$0.18 | -$0.18 |
| Q2 2026 | 3 | -$0.17 | -$0.17 | -$0.17 |
| Q3 2026 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q4 2026 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q1 2027 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q2 2027 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q3 2027 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q4 2027 | 1 | -$0.13 | -$0.13 | -$0.13 |
TELA Bio Inc last posted its earnings results on Wednesday, March 25th, 2026. The company reported $-0.16 earnings per share for the quarter, topping analysts' consensus estimates of $-0.18 by $0.02. The company had revenue of 20.87 M for the quarter and had revenue of 80.28 M for the year. TELA Bio Inc has generated $-1 earnings per share over the last year ($-0.83 diluted earnings per share) and currently has a price-to-earnings ratio of -1.3. TELA Bio Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/25/2026 | Q4 2025 | -$0.18 | -$0.17 | 0.01 | $21.03 M | $20.87 M |
| 11/14/2025 | Q3 2025 | N/A | -$0.19 | N/A | $21.78 M | $20.69 M |
| 08/11/2025 | Q2 2025 | -$0.18 | -$0.22 | -0.04 | $20.67 M | $20.20 M |
| 05/08/2025 | Q1 2025 | -$0.21 | -$0.25 | -0.04 | $17.36 M | $18.52 M |
| 03/21/2025 | Q4 2024 | N/A | -$0.23 | N/A | $23.19 M | $17.65 M |
| 11/08/2024 | Q3 2024 | N/A | -$0.42 | N/A | $18.85 M | $18.96 M |
| 08/13/2024 | Q2 2024 | N/A | -$0.51 | N/A | $18.45 M | $16.09 M |
| 05/10/2024 | Q1 2024 | N/A | -$0.23 | N/A | $16.32 M | $16.60 M |
| 03/22/2024 | Q4 2023 | N/A | -$0.53 | N/A | N/A | $17.00 M |
| 11/13/2023 | Q3 2023 | N/A | -$0.45 | N/A | N/A | $15.05 M |
| 08/10/2023 | Q2 2023 | N/A | -$0.46 | N/A | N/A | $14.49 M |
| 05/11/2023 | Q1 2023 | -$0.51 | -$0.73 | -0.22 | N/A | $11.91 M |
| 03/23/2023 | Q4 2022 | N/A | -$0.51 | N/A | N/A | $11.62 M |
| 11/10/2022 | Q3 2022 | N/A | -$0.71 | N/A | N/A | $11.16 M |
| 08/11/2022 | Q2 2022 | N/A | -$0.92 | N/A | N/A | $10.41 M |
| 05/11/2022 | Q1 2022 | N/A | -$0.82 | N/A | N/A | $8.23 M |
| 03/23/2022 | Q4 2021 | N/A | -$0.59 | N/A | N/A | $8.37 M |
| 11/12/2021 | Q3 2021 | N/A | -$0.57 | N/A | N/A | $7.65 M |
| 08/12/2021 | Q2 2021 | N/A | -$0.57 | N/A | N/A | $7.56 M |
| 05/14/2021 | Q1 2021 | N/A | -$0.56 | N/A | N/A | $5.88 M |
In the previous quarter, TELA Bio Inc (:TELA) reported $-0.16 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.18 by $0.02.
The conference call for TELA Bio Inc's latest earnings report can be listened to online.
The conference call transcript for TELA Bio Inc's latest earnings report can be read online.
TELA Bio Inc (:TELA) has a recorded annual revenue of $80.28 M.
TELA Bio Inc (:TELA) has a recorded net income of $-38,831,000.TELA Bio Inc has generated $-0.83 earnings per share over the last four quarters.
TELA Bio Inc (:TELA) has a price-to-earnings ratio of -1.3 and price/earnings-to-growth ratio is -0.02.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED